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ZIRCONIUM-PYRIBENZAMINE CREAM FOR THE
PROPHYLAXIS OF RHUS DERMATITIS*
RICHARD E. STRAUSS, CAPT., M.C.** AND CARL R. BRUCK, MAJOR, M.S.C.
Rhus dermatitis is one of the most common types of contact-type dermatitis
seen in the United States. Among Army personnel, poison ivy, oak, and sumac
dermatitis are a frequent occurrence since the soldiers inadvertently come into
contact with the offending weeds in order to carry out their required field duty.
Therefore, in areas where rhus growth is plentiful, a large proportion of dis-
pensary visits are for treatment of rhus dermatitis. Since many of these men have
to be excused from their normal duty and often hospitalized, the loss of useful
man-hours becomes a problem of maj or importance. It would be of great value,
therefore, if a prophylactic measure could be developed to reduce the incidence
of this dermatosis.
Several investigators (1, 2, 3, 4) have attempted to use various agents to
either inactivate or precipitate urushiol, the active principal of the various mem-
bers of the Rhus family. For the most part, none of the agents advocated have
been used on a large section of the population along with adequate controls.
Needless to say, unless a marked reduction in the incidence of rhus dermatitis
can be obtained, the application of any local medicament is not practical.
Recently, Cronk (5) reported the use of zirconium in the treatment of poison
ivy dermatitis. Further experimental studies (6) showed that the element zir-
conium inactivated urushiol in vitro and also prevented the development of rhus
dermatitis in human volunteers if it was applied within a short time after the
rhus toxin came in contact with the skin.
This report is a preliminary investigation on the use of a cream containing
4% zirconium hydrate and 2 % pyribenzamine hydrochloride in a water soluble
base as a prophylactic agent against poison oak under actual field conditions.
PROCEDURE
Subjects used for this study were all soldiers who were going on a three day
bivouac in an area known to have a dense growth of Rhus diversiloba (poison
oak). The soldiers from eight military companies were used for this study. The
companies were selected on the basis of occupying successively the same general
bivo!lac area, thus being exposed to approximately the same extent of rhus
foliage. The men from each company were divided into three groups: one group
was given zirconium-pyribenzamine cream; the second group received a placebo
cream with no active ingredients, to serve as a control; while the third group
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received no medication, to act as a further control. Instructions given to the men
were to apply the ointment on the hands, wrists, forearms7 face and neck (i.e.,
the most exposed areas) when they first arrived in the field, and thereafter when
they got up in the morning and during the day after washing.
All the soldiers were screened prior to going into the field and it was deter-
mined whether they had had attacks Qf rhus dermatitis previously. Three days
after the bivouac was completed, the soldiers were again interviewed. Anyone
who did not use his ointment as directed was not included in the final results.
Those men who had any type of dermatitis were examined by the dermatologist
and it was ascertained, as exactly as possible, if this was a contact dermatitis
with typical rhus characteristics.
TABLE I
Effect of zirconium-p yribenzamine cream on the prophylazis of poison oak dermatitis
METEOD
NO. WHO I
DE- I PER CENT
TOTAL VELOPED I WHO
NUM- POISON I DEVELOPED
BEE OAR I POISON OAK
DEE- DERMATITIS
MATITIS
NO. WITH
PREVIOUS
ATTACKS
POISON OAK
DERMATITIS
132
NO. WITH
PREVIOUS
ATTACKS POISON
OAK DERMATITIS
WHO REMAINED
CLEAR
106
PER CENT WITH
PREVIOUS
ATTACKS POISON
OAK DERMATITIS
WHO REMAINED
CLEAR
80.3%A. Zirconium-Pyriben- 323 31 I 9.6%
zamine Cream
B. Placebo Cream 228 50 I 21.9% 88 52 59.1%
C. No Local Medica- 355 73 20.6% 123 71 57.7%
tion
P <0.001 which greatly exceeds the minimal level for significant values.
RESULTS
A total of 906 men are included in the series and the incidence of poison oak
dermatitis for the three groups is shown in Table I. A correlation has also been
given showing the number of men who had previous attacks of rhus dermatitis
who remained clear of any dermatitis following their exposure during this test
period.
It is evident from the table that the zirconium-pyribenzamine cream gave a
sizable reduction in the incidence of poison oak dermatitis. Despite this fact,
there were still cases encountered in men who faithfully applied their cream as
directed. It must be remembered that the cream was only applied to the face,
neck, hands, and forearms. The rest of the body, as well as the soldier's clothes,
could still be contaminated by the plant. Most of the cases of poison oak dermati-
tis in the group which used zirconium-pyribenzamine cream first appeared on
the legs and genitalia (which were not protected). In the control groups, the
initial dermatitis occurred equally over the arms, face, legs or genitalia. Probably
the incidence of poison oak dermatitis could have been further reduced if the
zireonium-pyribenzamine cream had been applied to all portions of the body.
The placebo cream had no protective effect and the incidence of poison oak
dermatitis was actually a little greater than that of the group which used nothing.
The incidence of poison oak dermatitis varied considerably among the various
companies, but the proportions between the treated and untreated groups re-
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mained about the same. Some companies showed as much as a 40 % incidence
of rhus dermatitis among the controls, but the group using the active ointment
would then show oniy around a 20% incidence. This would seem to indicate
that the active ointment only gives a quantitative reduction in the incidence of
poison oak dermatitis and does not give complete protection under the conditions
used. Perhaps a stronger concentration of zirconium is necessary to obtain
greater protection.
One company of 109 men was not included in the results. Before any of these
men applied their cream, they were exposed to a heavy growth of Rhus diver-
siloba while sitting on a hillock receiving instructions in regard to the bivouac
procedures. None of these men applied their cream until approximately one hour
after this. In this company approximately 40% of the men developed poison oak
dermatitis, regardless of whether or not they applied either of the creams. It must
be assumed that the zirconium-pyribenzamine cream applied one hour or so
after exposure did not prevent the development of rhus dermatitis.
There were four men who claimed that the cream irritated their skin and pro-
duced a transient erythema when it was applied. However, two of these men
were using the placebo cream. Patch tests done at a later date on all four men
were negative. It is felt that this was not a true sensitivity to any of the active
ingredients in the cream.
It cannot be determined from this study whether the results are due to the
zirconium, the pyribenzamine, or a combination of the two agents. Further
studies are now under way using zirconium incorporated in a lotion for both
the prophylaxis and treatment of poison oak dermatitis. Dermatologic experi-
ence indicates that a lotion is a more suitable preparation for treatment of
acute eczematous eruptions.
SUMMARY
A 4% zirconium hydrate, 2% pyribenzamine hydrochloride cream applied to
the hands, forearms, face and neck of men being exposed to rhus diversiloba
under actual field conditions, reduced the incidence of poison oak dermatitis
from 21.1 % to 9.6%. Further studies are being conducted to see if the incidence
of poison oak dermatitis can be further reduced by increasing the strength of
zirconium and changing the mode of application.
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